Hyperfine, Inc. (HYPR)
NASDAQ·Healthcare·Medical - Devices
$1.31
+0.38%
Mkt Cap $106.22M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 18, 2026 | $5.16M | $5.29M | +2.68% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q4 2025 Nov 13, 2025 | $5.30M | $3.44M | -35.15% | -$0.10 | -$0.11 | -10.00% | — | — |
| Q3 2025 Aug 13, 2025 | $3.00M | $2.70M | -10.13% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q2 2025 May 13, 2025 | $3.19M | $2.14M | -33.06% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q1 2025 Mar 17, 2025 | $2.30M | $2.32M | +0.91% | -$0.16 | -$0.14 | +12.50% | — | — |
| Q4 2024 Nov 12, 2024 | $3.84M | $3.64M | -5.05% | -$0.14 | -$0.14 | +0.00% | — | — |
| Q3 2024 Aug 8, 2024 | $3.30M | $3.63M | +10.03% | -$0.14 | -$0.14 | +0.00% | — | — |
| Q2 2024 May 13, 2024 | $3.05M | $3.29M | +8.03% | -$0.14 | -$0.14 | +0.00% | — | — |
| Q1 2024 Mar 21, 2024 | $3.71M | $2.69M | -27.60% | -$0.17 | -$0.15 | +11.76% | — | — |
| Q4 2023 Nov 9, 2023 | $3.71M | $2.33M | -37.20% | -$0.15 | -$0.15 | +0.00% | — | — |
| Q3 2023 Aug 14, 2023 | $3.20M | $3.38M | +5.66% | -$0.17 | -$0.15 | +11.76% | — | — |
| Q2 2023 May 11, 2023 | $2.07M | $2.63M | +27.50% | -$0.16 | -$0.17 | -6.25% | — | — |
| Q1 2023 Mar 21, 2023 | $2.50M | $1.42M | -43.04% | -$0.25 | -$0.19 | +24.00% | — | — |
| Q4 2022 Nov 10, 2022 | $1.70M | $2.35M | +38.12% | -$0.26 | -$0.19 | +26.92% | — | — |
| Q3 2022 Aug 10, 2022 | $2.00M | $1.53M | -23.35% | -$0.27 | -$0.33 | -22.22% | — | — |
| Q2 2022 May 11, 2022 | $1.00M | $1.51M | +50.90% | -$0.21 | -$0.34 | -61.90% | — | — |
| Q1 2022 Mar 25, 2022 | — | $436.00K | — | — | -$2.73 | — | — | — |
| Q1 2022 Mar 23, 2022 | — | $371.00K | — | — | -$2.73 | — | — | — |
| Q3 2021 Aug 19, 2021 | — | $358.00K | — | — | -$0.21 | — | — | — |
| Q2 2021 May 17, 2021 | — | $331.00K | — | — | -$0.11 | — | — | — |